Nusinersen ema orphan designation date?

What was the orphan designation date for nusinersen (Spinraza)?

Nusinersen (Spinraza) received its European Medicines Agency (EMA) orphan designation on 20 June 2012. [1]

Where is this recorded (and what does it mean)?

EMA orphan designation is granted for medicines intended to treat, prevent, or diagnose rare diseases in the EU. The designation date is the date EMA records the medicine as eligible for orphan status, separate from the later date of marketing authorization. [1]

How can I verify it quickly?

You can confirm the date in EMA’s product/orphan designation information using the Spinraza (nusinersen) entry shown in the source record. [1]

Sources:
[1] https://www.ema.europa.eu/en/medicines/orphan-designations/eu-orphan-designations-database/nusinersen